Zhixiang Jintai
智翔金泰
Zhixiang Jintai
Biotech/Healthcare
Founded in 2015, Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. (Genrix Biopharmaceutical) focuses on the commercialization of novel monoclonal antibody drugs.
Latest round: Post-IPO (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.